Navigation Links
Biotechnology Leader to Exhibit at Upcoming Trade Show

ST. CLOUD, Minn., March 7 /PRNewswire/ -- DCI-Biolafitte (, a leading manufacturer of stainless steel GMP fermentors and bioreactors, control systems and software, will exhibit at the Interphex trade show at the Pennsylvania Convention Center in Philadelphia, March 26-28. DCI-Biolafitte will display R&D, lab-scale equipment, along with Nucleo(TM), the next generation of single-use bioreactors. DCI-Biolafitte will display at booth 231.

DCI-Biolafitte offers a full line of stirred tank bioreactors and fermentors from one-liter glass autoclavables to 40,000-liter GMP production- scale equipment. DCI-Biolafitte also recently announced that it will offer Nucleo, a single-use bioreactor that is scalable from laboratory to industrial applications.

DCI-Biolafitte is a joint venture between two world-renowned, stainless steel vessel manufacturers; Pierre Guerin-Biolafitte (, a French-based company, and DCI, Inc. a St. Cloud, Minnesota company. Pierre Guerin-Biolafitte has been providing fully automated processes and equipment to the food, beverage, and biotech industries for over 50 years and is a world-leader in engineering and design of stainless steel vessels, bioreactors and fermentors.

DCI, Inc. ( is a world leader in the manufacturing, servicing and support of stainless steel processing vessels for the pharmaceutical, bioscience, chemical and cosmetic industries, since 1955. DCI is committed to being the premier supplier of innovative solutions for our customers through superior design and fabrication.

For more information about: DCI-Biolafitte,

Pierre Guerin-Biolafitte,

DCI, Inc.,

To contact: DCI-Biolafitte, e-mail

DCI, Inc., e-mail

SOURCE DCI-Biolafitte
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New Books on Best Practices in Biotechnology Business Development and Biotechnology Education
2. Tunnell Consulting Expands Biotechnology Expertise
3. Genetic Engineering & Biotechnology News reports on advances in miRNA
4. ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board
5. Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008
6. Perrigo Company to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
9. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
10. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
Post Your Comments:
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. ... (Nasdaq: HART ), a biotechnology company developing bioengineered ... Jim McGorry will present at the LD ... 2015 at 2:30 p.m. PT. The presentation will be ... 30 days. Management will also be available at the ...
(Date:11/25/2015)... Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... business and prospects remain fundamentally strong and highlights ... doxorubicin) recently received DSMB recommendation to continue the ... review of the final interim efficacy and safety ... Endpoint in men with heavily pretreated castration- and ...
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
Breaking Biology Technology:
(Date:11/18/2015)...  As new scientific discoveries deepen our understanding of ... providers face challenges in better using that knowledge to ... as more children continue to survive pediatric cancer, that ... age. John M. Maris, M.D ., a ... (CHOP) . --> John M. Maris, ...
(Date:11/17/2015)... Mass. , Nov. 17, 2015 Pressure ... leader in the development and sale of broadly enabling, ... worldwide life sciences industry, today announced it has received ... its $5 million Private Placement (the "Offering"), increasing the ... $4,025,000.  One or more additional closings are expected in ...
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
Breaking Biology News(10 mins):